Sigachi

Hyderabad, India Founded: 1989 • Age: 37 yrs Listed
Manufacturer of microcrystalline cellulose

About Sigachi

Sigachi is a publicly listed company based in Hyderabad (India) founded in 1989. Manufacturer of microcrystalline cellulose. The company has 1,629 employees. Sigachi has completed 1 acquisition, including Trimax Bio sciences. Its chief executive, as recorded, is Amit Raj Sinha. Its website sigachi.com draws about 17 thousand monthly visits. Its Indian entity Sigachi Industries Limited reported revenue of β‚Ή486 Cr. Sigachi offers products and services including Pre Formulated Excipients, High Functionality Excipients, and Thickeners and Stabilizers. Its focus areas include High Tech, Advanced Materials, Nanostructures and Polymer.

Company details

Sigachi was established in 1989 in Hyderabad, India, as a producer of microcrystalline cellulose. Products are supplied across pharmaceutical, chemical, cosmetic, and food sectors through multiple series. Research and development efforts are focused on new molecule creation from initial concepts. Certifications and awards for microcrystalline cellulose advancements are maintained by the company.

  • Headquarters Hyderabad, India
  • Employees 1,629
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sigachi.com
  • Social LinkedIn X YouTube
  • Legal Name Sigachi Industries Limited
Key Metrics
  • Market Cap
    ₹1,037 Cr

    SIGACHI · NSE

  • Share Price
    ₹27.58

    +1.62% today

  • Revenue
    ₹478 Cr

    FY 2025-26 · -2.1% YoY

  • EBITDA
    −₹64.47 Cr

    Margin -13.5%

  • Net Profit
    ₹34.01 Cr

    FY 2025-26 · -51.1% YoY

  • P/E (TTM)
    39.4x

    P/B 1.9x

  • ROE
    5.9%

    ROCE 6.2%

  • Debt / Equity
    0.27

    Interest cover -16.9x

  • Latest Funding Round
    $34.58M (USD), Post-IPO

    Aug 2023

  • Employee Count
    1,629
  • Investments & Acquisitions

Products & Services of Sigachi

Sigachi offers a comprehensive portfolio of products and services, including Pre Formulated Excipients, High Functionality Excipients, and Thickeners and Stabilizers.

Pre Formulated Excipients
Pharmaceutical Excipients

Excipients for enhancing drug formulations and stability in pharmaceuticals.

High Functionality Excipients
Chemical Additives

Advanced excipients for improved performance in cosmetic and food products.

Thickeners and Stabilizers
Food Additives

Additives that provide consistency and stability in nutraceutical formulations.

Apps and channels of Sigachi

its YouTube channel Sigachi Industries Limited has 526 subscribers and 30 videos.

Sigachi Industries Limited
YouTube 526 subscribers 30 videos Travel & Events
Open channel

Videos from Sigachi

The most watched videos on Sigachi's YouTube channel, Sigachi Industries Limited (526 subscribers). Click a video to play it here.

CNBC Special Coverage on Sigachi's Success Journey
5K views
Sigachi's all-new product JOYMIX IC!
2.7K views
Birthday Celebrations @ Sigachi: #PawriHoRahiHai
1.2K views
How to select the best binders for Pharmaceutical Tablet Formulation?
1.1K views

More on Sigachi Industries Limited.

Funding Insights of Sigachi

  • Total Rounds 1
  • Last Round Post-IPO β€” $34.58M
  • First Round $34.58M

    (Aug 2023)

All 1 funding rounds of Sigachi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2023$34.58MPost-IPO––
–

Board of directors of Sigachi Industries Limited (Sigachi)

Sigachi Industries Limited is the primary company behind Sigachi. The boards of the 2 registered companies of Sigachi currently have 6 directors; the longest-serving is Rabindra Prasad Sinha, appointed in 1990. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rabindra Prasad Sinha
DIN 00413448
Whole-time director19 Jan 199036 yrs 9 moSigachi Industries Limited
Chidambarnathan Shanmuganathan
DIN 00485497
Director07 Oct 20206 yrs 1 moSigachi Technoserve Private Limited, Sigachi Industries Limited
Amit Raj Sinha
DIN 01263292
Director07 Oct 20206 yrs 1 moSigachi Technoserve Private Limited, Sigachi Industries Limited
Dhanalakshmi Guntaka
DIN 09363100
Director18 Oct 20215 yrsSigachi Industries Limited
Bindu Vinodhan
DIN 02882210
Director27 Oct 20224 yrsSigachi Industries Limited
Janardhana Reddy Yeddula
DIN 03207357
Director30 Nov 20241 yr 11 moSigachi Industries Limited

People of Sigachi

16 people are tracked at Sigachi (8 in leadership, 8 in team); the tracked headcount is 1,629.

NameRoleGroup
CEO & MDLeadership
Valdemir Passos
VP Of Technical & Commercial ServicesLeadership
Gani Raju
General Manager - SCMLeadership
Saumya Dubey
Senior Manager- CEO OfficeLeadership
Subbarami Reddy Oruganti
Chief Financial OfficerLeadership
Jaideep Jagdeeshwar Rao
VP – Strategy & OperationsLeadership
M E Elanghovan
VP – Operations, Hyderabad UnitLeadership
Prateek Patel
VP Quality & Audit (corporate Role)Leadership
Lovely Gupta
Sr. Executive MicrobiologyTeam
Sanjeev Reddy
Purchase ExecutiveTeam
Sanjiv Kumar
GM – QA & Ra, Gujarat UnitTeam
K Sudeer Kumar
GM – Sales & MarketingTeam
Venu M U
Human Resources ExecutiveTeam
Ashish Dhir
GM – GenericsTeam
Subramanian Ananthanarayan
SVP – Human ResourcesTeam
Bhavani Chidambaranathan
Business DevelopmentTeam
Premium access

Complete people profiles for Sigachi

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Sigachi

Sigachi is a publicly listed company on the NSE with ticker symbol SIGACHI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date15 Nov 2021
  • Listed onBSE: 543389 · NSE: SIGACHI
  • Listed entitySigachi Industries Limited
  • Exchange sectorHealth technology
  • ISININE0D0K01022
  • Share price₹28.16 (-0.39% on the day) · 2026-10-14
  • Market capitalisation₹1,081 Cr
  • Price to earnings42.4
  • EPS (diluted, trailing year)₹0.66
  • Dividend yield0.35%
  • Volume (last session)1,026,132

Financials of Sigachi

Exchange-reported figures of Sigachi Industries Limited, the listed company behind Sigachi (NSE: SIGACHI).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹478 Cr
-2.1% YoY
EBITDA
−₹64.47 Cr
-164.5% YoY
Profit After Tax
₹34.01 Cr
-51.1% YoY
Net Worth
₹522 Cr
-13.2% YoY
Total Assets
₹694 Cr
-8.5% YoY
Total Debt
₹162 Cr
+14.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue478488399302250193139
Revenue growth-2.1%+22.4%+32.1%+20.7%+29.9%+38.6%-
EBITDA(64.47)10076.6658.7353.0338.7924.75
EBITDA margin-13.5%+20.5%+19.2%+19.4%+21.2%+20.1%+17.8%
Profit before tax(87.70)92.3369.7854.4851.5938.4825.34
Net profit34.0169.5757.180.0039.9830.2620.32
Net profit margin+7.1%+14.3%+14.3%0.0%+16.0%+15.7%+14.6%
EPS (β‚Ή)(2.14)1.821.740.0013.0239.3926.44
Balance sheet
Total assets69475859433826411695.67
Net worth52260143026822894.2064.58
Total debt16214215168.4834.9020.9330.38
Cash & bank26.0172.0257.0632.7669.3818.0210.59
Net working capital25833022914716274.0061.44
Cash flow
Cash from operations(42.80)26.9312.8929.025.8529.5512.14
Cash from investing(5.45)(93.07)(161)(91.85)(62.86)(11.43)(6.82)
Cash from financing2.2481.1017226.21108(10.69)3.14
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue130121122117110128128139
Revenue growth (YoY)+18.1%-5.4%-4.9%-15.9%-11.6%+34.0%--
Other income0.221.001.350.477.153.942.192.02
EBITDA18.1216.5115.284.997.52(96.90)28.5533.18
EBITDA margin+13.9%+13.6%+12.5%+4.3%+6.8%-75.6%+22.3%+23.8%
Depreciation4.424.414.574.184.114.724.744.67
Interest3.853.014.333.133.133.313.333.82
Profit before tax10.0710.097.73(1.85)7.43(101)22.6726.71
Tax1.281.950.06(1.83)(3.09)(0.02)6.506.20
Net profit8.798.147.67(0.02)10.52(101)16.1720.51
EPS (β‚Ή)0.270.180.200.010.28(2.63)0.390.52
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue379408318290249188139
Revenue growth-7.1%+28.5%+9.4%+16.4%+32.7%+35.4%-
EBITDA(68.22)74.2759.2955.8250.3937.3224.70
EBITDA margin-18.0%+18.2%+18.7%+19.2%+20.2%+19.9%+17.8%
Profit before tax(84.55)70.7755.1351.5848.9637.1025.45
Net profit38.2547.6841.0141.5737.9829.0420.43
Net profit margin+10.1%+11.7%+12.9%+14.3%+15.2%+15.5%+14.7%
EPS (β‚Ή)(2.08)1.251.2513.5212.3737.8326.58
Balance sheet
Total assets60567554733526311695.71
Net worth47656041026622794.8966.56
Total debt12611313568.4034.7520.7828.44
Cash & bank18.0064.2049.2829.7768.6317.7610.11
Net working capital14726219414316174.4061.36
Cash flow
Cash from operations(3.48)35.6215.0527.685.3527.9011.93
Cash from investing(42.20)(90.31)(158)(92.83)(62.87)(11.43)(6.83)
Cash from financing(0.52)69.6116326.28108(8.82)3.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11398.2892.1092.0383.94111114105
Revenue growth (YoY)+35.2%-11.4%-18.9%-12.4%-23.1%+38.5%--
Other income0.220.441.330.477.153.941.772.05
Total expenses96.4185.1281.0385.5877.2820894.8583.89
EBITDA17.0713.1611.076.456.66(97.04)18.6921.19
EBITDA margin+15.0%+13.4%+12.0%+7.0%+7.9%-87.4%+16.5%+20.2%
Depreciation3.623.623.783.383.313.953.943.96
Interest3.162.192.942.522.532.152.803.36
Profit before tax10.517.795.681.027.97(99.20)13.7215.92
Tax1.541.290.76(1.92)(3.79)(0.06)6.756.24

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 11 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue130121122117110128128139
Revenue growth (YoY)+18.1%-5.4%-4.9%-15.9%-11.6%+34.0%--
Other income0.221.001.350.477.153.942.192.02
EBITDA18.1216.5115.284.997.52(96.90)28.5533.18
EBITDA margin+13.9%+13.6%+12.5%+4.3%+6.8%-75.6%+22.3%+23.8%
Depreciation4.424.414.574.184.114.724.744.67
Interest3.853.014.333.133.133.313.333.82
Profit before tax10.0710.097.73(1.85)7.43(101)22.6726.71
Tax1.281.950.06(1.83)(3.09)(0.02)6.506.20
Net profit8.798.147.67(0.02)10.52(101)16.1720.51
EPS (β‚Ή)0.270.180.200.010.28(2.63)0.390.52
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue478488399302250193139
Revenue growth-2.1%+22.4%+32.1%+20.7%+29.9%+38.6%-
Other income8.2520.5211.696.672.633.254.89
Total expenses542388322243197154114
Employee cost0.0066.7250.3332.2316.5513.9311.71
EBITDA(64.47)10076.6658.7353.0338.7924.75
EBITDA margin-13.5%+20.5%+19.2%+19.4%+21.2%+20.1%+17.8%
Depreciation17.5815.7810.806.632.902.311.96
Interest13.9012.417.774.291.171.252.34
Profit before tax(87.70)92.3369.7854.4851.5938.4825.34
Tax(4.89)21.8612.5110.9411.568.225.02
Net profit34.0169.5757.180.0039.9830.2620.32
Net profit margin+7.1%+14.3%+14.3%0.0%+16.0%+15.7%+14.6%
EPS (β‚Ή)(2.14)1.821.740.0013.0239.3926.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital38.2138.2132.8230.7430.747.687.68
Reserves & surplus48456333923819786.5256.90
Shareholders' funds (net worth)52260143026822894.2064.58
Minority interest7.1612.2311.390.000.000.000.00
Secured loans12811011941.2934.7520.7828.36
Unsecured loans34.1532.0332.5027.190.150.152.02
Total debt16214215168.4834.9020.9330.38
Total liabilities69475859433826411695.67
Assets
Gross block39643730514569.0950.7342.05
Net block32537025412253.4137.9631.59
Capital work in progress30.608.5997.2734.909.713.743.13
Investments0.150.150.290.150.150.150.00
Inventories73.5994.2770.7246.6030.4521.2027.92
Sundry debtors22418415080.1760.1235.7627.60
Cash & bank balances26.0172.0257.0632.7669.3818.0210.59
Loans & advances65.5544.3635.4517.8819.9112.165.95
Total current assets38939431317718087.1472.06
Total current liabilities13164.4383.7930.2217.7513.1410.62
Net working capital25833022914716274.0061.44
Total assets69475859433826411695.67
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash72.0257.0632.8169.3818.0210.592.13
Net cash from operating activities(42.80)26.9312.8929.025.8529.5512.14
Net cash from investing activities(5.45)(93.07)(161)(91.85)(62.86)(11.43)(6.82)
Net cash from financing activities2.2481.1017226.21108(10.69)3.14
Net change in cash(46.01)14.9624.25(36.63)51.377.438.46
Closing cash26.0172.0257.0632.7669.3818.0210.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-2.1%+22.4%+32.1%+20.7%+29.9%+38.6%-
EBITDA growth-164.5%+30.5%+30.5%+10.8%+36.7%+56.7%-
PBT growth-+32.3%+28.1%+5.6%+34.1%+51.9%+2.5%
Net income growth-51.1%+21.7%--100.0%+32.1%+48.9%-
Revenue CAGR (3Y)+16.5%+25.0%+27.4%+29.5%+24.7%+24.2%-
EBITDA CAGR (3Y)-+23.5%+25.5%+33.4%+26.9%+49.0%-
Profitability & leverage
Net income margin-17.3%+14.4%+14.4%+14.4%+16.0%+15.7%+14.6%
Return on capital employed+6.2%+15.8%+16.8%+19.5%+27.8%+37.6%+33.3%
Return on net worth+5.9%+13.7%+16.4%+17.6%+24.9%+38.1%+37.1%
Debt / equity0.270.280.310.210.170.320.51
Long-term debt / equity0.040.070.100.050.010.020.03
Interest cover-16.9414.7411.808.232.333.4310.27
Efficiency & per share
Fixed asset turnover1.151.311.772.834.184.163.52
Inventory turnover5.695.926.807.849.697.855.51
Debtors turnover2.342.933.474.315.226.085.32
EPS (β‚Ή)(2.14)1.821.740.0013.0239.3926.44
Dividend per share (β‚Ή)0.100.100.101.001.000.001.00
Book value per share (β‚Ή)13.6515.7211.3287.2974.09122.6284.07
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11398.2892.1092.0383.94111114105
Revenue growth (YoY)+35.2%-11.4%-18.9%-12.4%-23.1%+38.5%--
Other income0.220.441.330.477.153.941.772.05
Total expenses96.4185.1281.0385.5877.2820894.8583.89
EBITDA17.0713.1611.076.456.66(97.04)18.6921.19
EBITDA margin+15.0%+13.4%+12.0%+7.0%+7.9%-87.4%+16.5%+20.2%
Depreciation3.623.623.783.383.313.953.943.96
Interest3.162.192.942.522.532.152.803.36
Profit before tax10.517.795.681.027.97(99.20)13.7215.92
Tax1.541.290.76(1.92)(3.79)(0.06)6.756.24
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue379408318290249188139
Revenue growth-7.1%+28.5%+9.4%+16.4%+32.7%+35.4%-
Other income8.2320.0811.576.672.633.254.89
Total expenses447334258234199151114
Employee cost0.0050.7742.7829.9815.4913.4011.65
EBITDA(68.22)74.2759.2955.8250.3937.3224.70
EBITDA margin-18.0%+18.2%+18.7%+19.2%+20.2%+19.9%+17.8%
Depreciation14.4312.928.716.622.902.311.96
Interest10.1310.667.024.291.161.162.18
Profit before tax(84.55)70.7755.1351.5848.9637.1025.45
Tax(5.01)23.0914.1210.0110.938.065.02
Net profit38.2547.6841.0141.5737.9829.0420.43
Net profit margin+10.1%+11.7%+12.9%+14.3%+15.2%+15.5%+14.7%
EPS (β‚Ή)(2.08)1.251.2513.5212.3737.8326.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital38.2138.2132.8230.7430.747.687.68
Reserves & surplus43852131923519687.2158.88
Shareholders' funds (net worth)47656041026622794.8966.56
Secured loans99.4888.6511141.2934.7520.7828.36
Unsecured loans26.7024.1124.0327.110.000.000.08
Total debt12611313568.4034.7520.7828.44
Total liabilities60567554733526311695.71
Assets
Gross block25529716914469.0950.7342.05
Net block21125413912253.4137.9631.59
Capital work in progress26.874.8791.1834.909.713.743.13
Investments1391021021.850.280.280.13
Inventories34.0038.1030.9332.9916.5415.3926.01
Sundry debtors12413411091.1572.2342.0530.05
Cash & bank balances18.0064.2049.2829.7768.6317.7610.11
Loans & advances77.9577.8857.8717.5619.9112.165.95
Total current assets25331424817117787.3672.12
Total current liabilities10752.1953.3528.2716.0812.9610.76
Net working capital14726219414316174.4061.36
Total assets60567554733526311695.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash64.2049.2829.7768.6317.7610.112.01
Net cash from operating activities(3.48)35.6215.0527.685.3527.9011.93
Net cash from investing activities(42.20)(90.31)(158)(92.83)(62.87)(11.43)(6.83)
Net cash from financing activities(0.52)69.6116326.28108(8.82)3.00
Net change in cash(46.21)14.9219.51(38.86)50.877.658.10
Closing cash18.0064.2049.2829.7768.6317.7610.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-7.1%+28.5%+9.4%+16.4%+32.7%+35.4%-
EBITDA growth-191.9%+25.3%+6.2%+10.8%+35.0%+51.1%-
PBT growth-+28.4%+6.9%+5.4%+32.0%+45.8%+0.2%
Net income growth-19.8%+16.3%-1.4%+9.5%+30.8%+42.1%-
Revenue CAGR (3Y)+9.3%+17.8%+19.1%+27.9%+24.9%+22.6%+19.6%
EBITDA CAGR (3Y)-+13.8%+16.7%+31.2%+23.9%+44.2%+39.2%
Profitability & leverage
Net income margin-21.0%+11.7%+12.9%+14.3%+15.3%+15.5%+14.7%
Return on capital employed+6.8%+13.3%+14.1%+18.7%+26.4%+36.1%+33.2%
Return on net worth+7.4%+9.8%+12.1%+16.9%+23.6%+36.0%+36.1%
Debt / equity0.230.260.300.210.170.300.46
Long-term debt / equity0.040.070.110.050.010.020.03
Interest cover-12.2617.3813.888.722.443.319.59
Efficiency & per share
Fixed asset turnover1.371.752.032.724.164.053.51
Inventory turnover10.5111.829.9311.7215.629.085.86
Debtors turnover2.943.353.163.554.365.215.02
EPS (β‚Ή)(2.08)1.251.2513.5212.3737.8326.58
Dividend per share (β‚Ή)0.100.100.101.001.000.001.00
Book value per share (β‚Ή)12.4514.6510.7386.3973.90123.5286.64

Investments & Acquisitions by Sigachi

Sigachi has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Trimax Bio sciences.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Non-infringing pharmaceutical research and healthcare products are developed.
trimaxbiosciences.comRaichur, India2011Aug 2023β€’β€’β€’β€’
Premium access

Complete acquisition details for Sigachi

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sigachi

4 dated milestones of Sigachi across 34 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sigachi is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $34.6M.
  4. Acquisition Acquires Trimax Bio sciences.

Web traffic of Sigachi

The website of Sigachi (sigachi.com) receives about 16.7K visits a month.

  • Monthly visits
    16.7K

    ▲ 32.9% vs previous month

Similar websites

Websites whose visitors overlap most with Sigachi. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nseindia.com
100%
19.9M#2,783View details
screener.in
screener.in
100%
#1,968–
eris.co.in
96%
35.5K#776,236View details
myinvestmentideas.com
myinvestmentideas.com
95%
#542,121–
fortuneindia.com
75%
324K#147,099View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Sigachi

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sigachi

Premium access

Complete news archive for Sigachi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sigachi

Sigachi was founded in 1989 and raised its 1st funding round 34 years after it was founded.

Sigachi is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Amit Raj Sinha is the CEO of Sigachi, as recorded in our data.

Sigachi has 1,629 employees.

The primary company behind Sigachi, Sigachi Industries Limited, reported revenue of β‚Ή486 Cr for FY 2026, down 2% year on year.

Sigachi was established in 1989 in Hyderabad, India, as a producer of microcrystalline cellulose. Products are supplied across pharmaceutical, chemical, cosmetic, and food sectors through multiple series. Research and development efforts are focused on new molecule creation from initial concepts. Certifications and awards for microcrystalline cellulose advancements are maintained by the company.

Sigachi offers Pre Formulated Excipients, High Functionality Excipients, and Thickeners and Stabilizers.

Yes, Sigachi is publicly traded on NSE under the ticker symbol SIGACHI.

Sigachi has made 1 acquisition, including Trimax Bio sciences.

Sigachi is associated with 2 legal entities: Sigachi Industries Limited, Sigachi Technoserve Private Limited.

The legal entities of Sigachi currently have 9 directors, including Chidambarnathan Shanmuganathan, Amit Raj Sinha, Subbarami Oruganti Reddy and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available